SCHEMBL9890053

SCHEMBL9890053

c1ccc2c(c1)oc1cc3c4ccccc4n(-c4ccc(-n5c6ccccc6c6cc7oc8ccccc8c7cc65)cc4)c3cc12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.48
ATM Q13315 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
AHR P35869 2/20 0.46
MAPT P10636 6/20 0.42
MEN1 O00255 4/20 0.42
KMT2A Q03164 4/20 0.42
ALDH1A1 P00352 4/20 0.42
HPGD P15428 4/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
NPC1 O15118 2/20 0.42
RAB9A P51151 1/20 0.42
MAOA P21397 3/20 0.39
PTPN1 P18031 1/20 0.38
CYP1A2 P05177 2/20 0.36
HSD17B10 Q99714 2/20 0.36
GLA P06280 1/20 0.36
CYP3A4 P08684 1/20 0.36
PGAM1 P18669 1/20 0.36
CASP1 P29466 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17245978 1.00 KDM4E (0.48) KDM4EATML3MBTL1AHRMAPT
SCHEMBL9890050 0.95 KDM4E (0.44) KDM4EATML3MBTL1AHRMAPT
SCHEMBL24676177 0.95 KDM4E (0.44) KDM4EATML3MBTL1AHRMAPT
SCHEMBL24676476 0.95 KDM4E (0.44) KDM4EATML3MBTL1AHRMAPT
SCHEMBL24174411 0.95 KDM4E (0.44) KDM4EATML3MBTL1AHRMAPT
SCHEMBL18620221 0.95 KDM4E (0.56) KDM4EATML3MBTL1AHRMAPT
SCHEMBL17228855 0.95 KDM4E (0.56) KDM4EATML3MBTL1AHRMAPT
SCHEMBL17245935 0.94 MAPT (0.44) KDM4EATML3MBTL1AHRMAPT
SCHEMBL18381822 0.94 KDM4E (0.55) KDM4EATML3MBTL1AHRMAPT
SCHEMBL17245942 0.94 AHR (0.44) KDM4EATML3MBTL1AHRMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230033529-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-02-02 US disclosed
US-20220238815-A1 ORGANIC ELECTROLUMINESCENT ELEMENT, COMPOUND, AND ELECTRONIC APPLIANCE IDEMITSU KOSAN CO.,LTD. (JP) 2022-07-28 US disclosed
US-20120138915-A1 ORGANIC ELECTROLUMINESCENCE DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2012-06-07 US disclosed
US-20120138915-A1 ORGANIC ELECTROLUMINESCENCE DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2012-06-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230033529-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC DEVICE LEF1, L1CAM, RAP1A KDM4E 3096/4885ATM 2806/4885L3MBTL1 173/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.